Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage

NCT06221046 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Moisture Associated Skin Damage
Incontinence Associated Dermatitis
Fecal Incontinence

Interventions

DRUG: Control (Standard treatment)
OTHER: Novel Barrier Cream

Sponsor

Scotiaderm

Collaborators

[object Object]